-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%208-11.pdf
June 02, 2025 - Tables 8-11
Table 8. … Table 9. … Table 10. … Table 11.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%201-7.pdf
June 02, 2025 - Tables 1-7
Table 1. … Contingency Table for Presence of Chart Review Exclusions
Senior Abstractor
Identified Chart-Based … Contingency Table for Presence of Seizure in Administrative Claims and Charts
Seizure in Claims … Table 3. … Table 4.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-section-7.pdf
June 02, 2025 - Tables 11-14
Table 11. … Table 12. … Table 13. … Table 14.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-7-10.pdf
June 02, 2025 - Tables 7-10
TABLE 7
Quantile
Percent in Poverty
Maximum 49.9%
99 37.5%
95 28.9% … 90 25.7%
75 20.7%
50 16.5%
25 12.5%
10 10.0%
5 8.6%
1 6.1%
Minimum 2.9%
TABLE 8 … TABLE 9
UIC_2013
UIC_2013 Frequency Percent
1 432 13.74
2 735 23.39
3 130 4.14
4 … 7 162 5.15
8 269 8.56
9 184 5.85
10 189 6.01
11 125 3.98
12 182 5.79
TABLE … 7
HROB Table 8
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-2-5.pdf
June 02, 2025 - Tables 2-5 … TABLE 2
High-risk … 35] 29% [25, 33] 0.01
Proportion funded by
private insurance*
45% [25, 65] 35% [20, 70] 0.22
TABLE … TABLE … 1.4%)
In-hospital coverage
unnecessary
5 (6.3%) 1 (10%) 17 (28.8%) 89 (64.0%)
TABLE
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-5-tables.pdf
January 01, 2007 - Section 5, Tables
Outcome
Measure
Restrictive
strategy n (%)
Liberal strategy
n (%)
P value … 22.2%) 118 (28.1%) 0.05
Multiple organ
dysfunction
adjusted score
10.7±7.5 11.8±7.7 0.03
Table … (3%) 8 (3%) 0.50
28-day mortality 14 (4%) 14 (4%) 0.98
New MODS 38 (12%) 39 (12%) NI
Table … days 6.0 ± 5.4 days 0.76
ICU stay after
randomization
9.5 ± 7.9 days 9.9 ± 7.4 days 0.39
Table
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-section-6.pdf
January 01, 2006 - Tables 7-10
Table 7: Ratio of All MRI to All CT Scans within 30 days of Evaluation for Atraumatic Headache … Table 8. … 4990 17466 0.99
Texas 7755 28147 1.00
Utah 332 988 0.90
Median (range) 0.99 (0.90-1.00)
Table … 9: Contingency Table for Presence of Exclusions in Administrative Claims and Charts for Children with … 10: Contingency Table for Presence of Exclusions in Administrative Claims and Charts for Children with
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chirpa-215-scd-ed-tables.pdf
January 01, 2002 - Tables 1-7
Table 1: Codes to Identify Sickle Cell Disease Name Hemoglobin Screening Result ICD‐9 Code … SD‐disease Hb F,S,D 282.68, 282.69
Hb SS‐disease (sickle cell anemia) Hb F,S 282.61, 282.62
Table … Table 3. … Table 5. … Table 6.
-
meps.ahrq.gov/data_stats/summ_tables/insr/state/series_10/2021/ic21_xc_e.pdf
January 01, 2021 - IC Tables
Table X.C Premium distributions (in dollars) for private-sector employees enrolled in single … Table X.C Standard errors for premium distributions (in dollars) for private-sector employees enrolled … Table X.C.1 Employee contribution distributions (in dollars) for private-sector employees enrolled in … Table X.C.2 Employer cost distributions (in dollars) for private-sector employees enrolled in single … IC Tables
Table X.C Premium distributions (in dollars) for private-sector employees enrolled in single
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-section-6-b.pdf
June 02, 2025 - Section 6.B, Validity Tables … Validity - Tables
Table 1. … 5.15%
CA 7.70% 11.88%
MI 8.05% 1.93%
KS 9.44% 16.36%
Total 6.64% 9.81%
Correlation 0.00758
Table
-
hcup-us.ahrq.gov/reports/trendtables/summarytrendtables.jsp
May 01, 2025 - HCUP Summary Trend Tables … The HCUP Summary Trend Tables include downloadable Microsoft® Excel tables with information on the following … Graphs from HCUP Summary Trend Tables
A focused report with graphs derived from Table 2d displays the … HCUP Summary Trend Tables
The following is a list of the available HCUP Summary Trend Tables. … Internet Citation: HCUP Summary Trend Tables.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-3-a-tables.pdf
June 02, 2025 - Section 3-A, Tables
Outcome Transfused Not transfused P value
Patients 131 109
Average entry … 8.6 ± 9.8 days 5.7 ± 7.6 days < 0.001
Hospital LOS 18.9 ± 17.6 days 12.4 ± 10.5 days < 0.001
Table … days days days 1.32 days days
Significance p<0.0012 P<0.0003 p=0.0047 P=0.0009 P=0.0012
Table
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-6-table-9.pdf
June 02, 2025 - Section 6, Tables 7-9
Table 9: Documentation of Heart Rate for Children with Severe Sepsis or Septic
-
meps.ahrq.gov/data_stats/summ_tables/insr/state/series_9/2021/ic21_ixa_e.pdf
January 01, 2021 - IC Tables - 6
Table IX.A.1 Health insurance offer, eligibility and take up rates for private-sector … Table IX.A.1 Standard errors for health insurance offer, eligibility, take up rates for private-sector … Table IX.A.3 Health insurance offer, eligibility and take up rates for private-sector establishments … Table IX.B.1 Health insurance offer, eligibility and take up rates for private-sector establishments … Table IX
Table IX.A.1 Health insurance offer, eligibility and take up rates for private-sector establishments
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.pdf
May 29, 2025 - 1
Table 1. … Digestive and Urinary Neoplasms
13 Other Neoplasms
14 Benign Neoplasms of Skin, Breast, Eye
7
Table … Monoclonal antibodies Trastuzumab 12 months 88.4 9.0 2.0 2.2 10.9 0.5 1.4 4.5 5.5
11
Table … Kinase inhibitors Trastuzumab American
Indian/Alaska
Native
0.3 * * * 0.0 * * * *
28
Table
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.xls
May 29, 2025 - OT.1
Table 1. … Digestive and Urinary Neoplasms
13 Other Neoplasms
14 Benign Neoplasms of Skin, Breast, Eye
OT.3
Table … Antibodies TRASTUZUMAB 12 months 88.44% 8.99% 2.03% 2.23% 10.95% 0.46% 1.44% 4.45% 5.49%
OT.4
Table … 0.1%
Kinase Inhibitors TRASTUZUMAB American Indian/Alaska Native 0.3% - - - 0.0% - - - -
OT.5
Table
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-tables-8-11.pdf
June 02, 2025 - CHIPRA 207: Tables 8-11 … Tables … 8a-e: Risk Model Estimates using Adjusted Model
Table 8a. … Tables … 11: Correlation with Complication Rates
Table 11.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
June 02, 2025 - Section 1, Tables 1-4
1
Table 1: Definition of Severe Sepsis and Septic Shock
Term Definition … times upper limit of normal for age
Septic Shock Sepsis and cardiovascular organ dysfunction
3
Table … Severe Sepsis or
Septic Shock
For children who are not hypotensive: resolution of tachycardia (see Table … For children who are hypotensive: resolution of hypotension (see Table 4) PLUS
resolution of any 1 … • Tachycardia (see Table 4)
4
Table 4: Age-Specific Vital Signs and Laboratory Variables
Age
-
hcup-us.ahrq.gov/reports/methods/MS-2021-04-Appendix.xlsx
January 01, 2021 - Appendix A Data Tables
Title Page
26-Aug-15
HCUP METHODS SERIES REPORT 2021-04 … Census Bureau, https://www.census.gov/data/tables/2017/demo/popest/nation-total.html. … Census Bureau, https://www.census.gov/data/tables/2016/demo/popest/nation-total.html. … http://www.census.gov/popest/data/state/totals/2013/tables/NST-EST2013-01.xls. … Table A.6
Table A.6 Annual Estimates of the U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_tables.xlsx
January 01, 2009 - 1. Antidiab
Prevalence of Drugs by Antidiabetic Class, Among Medicare Parts A, B, and D FFS Population With Diabetes, by Age, Gender, and Race, 2006-2009
Age is calculated as of December 31 of the year.
Note: A dash signifies small cell count (<11).
Breakdown Category Year Alpha Glucosidase Inhibitors Amylin A…